Resonance Specialties, manufacturer of pyridine, picolines, cynopyridines, drug intermediates and APIs, has reported total income of Rs.18.75 crores during the period ended December 31, 2020 as compared to Rs.22.76 crores during the period ended September 30, 2020.

The company reported total income Rs.16.89 crores during the period ended December 31, 2019.

Resonance Specialties has posted net profit of Rs.3.25 crores for the period ended December 31, 2020 as against net profit of Rs.3.96 crores for the period ended September 30, 2020.

The company posted net profit of Rs.2.41 crores for the period ended December 31, 2019.

Resonance Specialties has reported total income of Rs.52.62 crores during the 9 months period ended December 31, 2020 as compared to Rs.45.63 crores during the 9 months period ended December 31, 2019.

The company has posted net profit of Rs.7.83 crores for the 9 months period ended December 31, 2020 as against net profit of Rs.4.24 crores for the 9 months period ended December 31, 2019.

The company has reported EPS of Rs.6.79 for the 9 months period ended December 31, 2020 as compared to Rs.3.68 for the 9 months period ended December 31, 2019.